Resources
Find the publications relevant to your drug development programs.
Drug Type
- Oncolytic Virus
- T-cell Engager
- Bispecific
- Small Molecule/Tyrosine Kinase Inhibitors
- Adoptive Cell Therapies
- Antibody Dependent Cellular Cytotoxicity
- Checkpoint Inhibitors
- Cell Therapies
- Antibody Drug Conjugates
- Other
Cancer Type
- Lung
- Kidney
- Brain
- NSCLC
- HNSCC
- Renal
- Colorectal
- Bladder
- Other
- Endometrial
- Melanoma
- Ovarian
Need Help?
Contact Us for support
Nov 13, 2019
Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples
Apr 15, 2026
Ex vivo evaluation of a MUC1-targeted bispecific T-cell engager in ovarian tumoroids using Nilogen’s 3D-EXpress platform
May 01, 2025
Advancing CAR-T Cell Therapies using Nilogen’s Ex Vivo 3D Tumoroid Platform AACR 2025
May 01, 2025
Preliminary Report of the TUMORIN Trial (Using Ex Vivo Tumoroids to Predict Immunotherapy Response in NSCLC) AACR 2025
Nov 16, 2024
Enhancing T Cell Persistence in Adoptive Cell Therapy: Leveraging Tumoroid-based Ex Vivo Assay for Preclinical Evaluation SITC 2024
Nov 16, 2024
Harnessing Tumoroids to Advance CAR-T Cell Therapies SITC 2024
